Unmatched sample | Matched sample | ||||
---|---|---|---|---|---|
All | Treated group | Control group | |||
Variables | N = 26,244 | N = 2,116 | N = 1,058 | N = 1,058 | |
Health-related | |||||
Incretin-based treatment | 6.09 | 50.00 | 100.00 | 0.00 | |
Hospital use in the previous year | 16.36 | 20.35 | 21.37 | 19.38 | |
Number of days in hospital† | 9.69 ± 17.34 | 10.11 ± 16.06 | 10.53 ± 14.62 | 9.66 ± 17.48 | |
At least one GP visit | 97.06 | 96.55 | 96.30 | 96.80 | |
Number of GP visits† | 6.90 ± 5.58 | 7.72 ± 4.69 | 7.49 ± 5.02 | 6.95 ± 4.32 | |
At least one endocrinologist visit | 6.54 | 14.10 | 13.88 | 14.31 | |
Number of endocrinologist visits† | 2.08 ± 1.29 | 2.19 ± 1.20 | 2.22 ± 1.08 | 2.17 ± 1.30 | |
Type of therapy for diabetes | |||||
Monotherapy | 59.11 | 1.95 | 1.94 | 1.96 | |
Dual therapy | 25.79 | 47.19 | 48.01 | 46.40 | |
Triple therapy | 4.55 | 34.00 | 35.06 | 32.98 | |
Insulin therapy | 10.55 | 16.86 | 14.99 | 18.67 | |
Polypharmacy | 7.00 ± 4.10 | 7.24 ± 4.09 | 7.21 ± 4.23 | 7.28 ± 3.95 | |
Diabetes follow-up (score) | 0.55 ± 0.22 | 0.58 ± 0.21 | 0.59 ± 0.21 | 0.57 ± 0.22 | |
Sociodemographic | |||||
Age | 71.72 ± 9.35 | 69.94 ± 9.28 | 69.84 ± 9.19 | 70.85 ± 9.37 | |
Female | 48.12 | 44.33 | 48.01 | 40.80 | |
Living with partner | 69.59 | 69.49 | 68.55 | 70.40 | |
Working | 13.02 | 14.64 | 14.06 | 15.20 | |
100% coverage status | 85.08 | 91.30 | 89.18 | 93.33 | |
Income | 2227.80 ± 1459.41 | 2254.11 ± 1936.50 | 2224.07 ± 1016.14 | 2282.98 ± 2522.46 | |
Patient’s environment | |||||
Location in a rural area (local level) | 5.69 | 5.39 | 5.27 | 5.51 | |
Share of diabetes-related deaths (county level) | 2.13 ± 0.68 | 2.18 ± 0.71 | 2.16 ± 0.65 | 2.20 ± 0.77 | |
Density of hospital beds | 642.69 ± 160.71 | 642.63 ± 154.13 | 645.34 ± 145.95 | 640.23 ± 162.81 |